Veru Stock Price

-0.22 (-3.09%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Veru Inc VERU NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.22 -3.09% 6.89 20:00:00
Open Price Low Price High Price Close Price Prev Close
7.12 6.84 7.12 6.90 7.11
Bid Price Ask Price Spread News
6.70 6.89 0.19 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,461 673,743 $ 6.92 $ 4,661,775 - 2.30 - 24.56
Last Trade Time Type Quantity Stock Price Currency
19:59:42 formt 500 $ 6.89 USD


Draw Mode:

Veru Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 549.02M 79.68M 63.95M $ 42.59M $ 3.17M -0.28 -247.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -30.00k 19.50%

more financials information »

Veru News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VERU Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week7.017.506.5517.12750,153-0.12-1.71%
1 Month8.328.846.5517.71853,050-1.43-17.19%
3 Months9.10511.186.5518.301,376,719-2.22-24.33%
6 Months9.0024.566.55113.312,512,387-2.11-23.44%
1 Year3.335424.562.3010.363,018,2793.55106.57%
3 Years2.0424.561.189.281,173,3254.85237.75%
5 Years1.3224.560.72228.83751,9225.57421.97%

Veru Description

Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.